|
Status |
Public on May 24, 2016 |
Title |
A549_control |
Sample type |
RNA |
|
|
Source name |
A549 cells
|
Organism |
Homo sapiens |
Characteristics |
cell line: A549 agent: 0.1% DMSO time point: 48h
|
Treatment protocol |
A549 lung cancer cells were treated with 0.1% DMSO, cordycepin 60 ug/mL, and cordyceps 100 ug/mL for 48hrs.
|
Growth protocol |
A549 cells were grown in DMEM supplemented with 10% fetal bovine serum, 1% penicillin-streptomycin, 10 mM nicotinamide, 10 μM troglitazone, and 16.7 μM zinc sulfate. Cells were cultured in humidified incubator at 37℃ and 5% CO2.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was prepared using theTrizol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was quantified using a NanoDrop spectrophotometer and quality was monitored with the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).
|
Label |
Cy3
|
Label protocol |
Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the One-Color Low RNA Input Linear Amplification PLUS kit (Agilent) according to the manufacturer's instructions.
|
|
|
Hybridization protocol |
Complementary RNA was hybridized using the Agilent`s Gene Expression Hybridization Kit.
|
Scan protocol |
Slides were scanned immediately after washing on the Agilent DNA Microarray Scanner (G2505B) using one color scan setting for array slides.
|
Description |
A549 lung cancer cells were treated with 0.1% DMSO for 48hrs
|
Data processing |
The scanned images were analyzed Agilent's GeneSpring Software.
|
|
|
Submission date |
May 23, 2016 |
Last update date |
May 24, 2016 |
Contact name |
Jung Min Kim |
E-mail(s) |
jmkim2010@korea.com
|
Phone |
82-10-3459-4776
|
Organization name |
NAR Center, Inc. & Genoplan, Inc.
|
Department |
Department of Health Genomics
|
Lab |
Genetics & Genomics
|
Street address |
Gangnam-gu Teheran-ro 216
|
City |
Seoul |
ZIP/Postal code |
06221 |
Country |
South Korea |
|
|
Platform ID |
GPL21185 |
Series (1) |
GSE81727 |
Cordycepin induces apoptosis by caveolin-1 mediated JNK’s regulation of Foxo3a in lung cancer A549 cells |
|